Marketing-authorisation holder · United States
Glaukos
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EPIOXA HD/EPIOXA KIT5'-phosphate sodium eq 0.239% base/ml · Solution/drops | Vitamin b2 | United States | Marketed | 2025 |
| IDOSE TR75mcg · Implant | Travoprost | United States | Marketed | 2023 |
| MITOSOL0.2mg/vial · For solution | Mitomycin | United States | Marketed | 2012 |
| PHOTREXA VISCOUS IN DEXTRAN 20%5'-phosphate 0.146% · Solution/drops | Vitamin b2 | United States | Marketed | 2016 |
| PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA5'-phosphate sodium eq 0.146% base/ml · Solution/drops | Vitamin b2 | United States | Marketed | 2016 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 | 0 | CompaniesAll medicines |